Akromioklavikulargelenkverletzungen

There is some controversy over the treatment of acromioclavicular injuries. The use of the Rockwood classification as the basis for decisions on whether operative or nonoperative treatment is indicated is discussed critically, and the authors' preferred operative technique is described and illustrated by examples. We treat injuries classified according to the Rockwood classification as types I and II with conservative methods. In type III injuries the patient's age, job and free time activities determine whether or not surgery is indicated. In the case of type IV or type VI injuries we always perform temporary internal fixation of the acromioclavicular joint, using transarticular K-wire fixation or hookplate osteosynthesis. Satisfactory results of both operative and nonoperative treatment are reported in the literature. The authors' own results are presented.     

Treating the cognitive deficits of schizophrenia

Schizophrenia is characterized by significant cognitive impairments that predict impairment in multiple domains of community outcome. Pharmacologic and psychosocial treatments are available that address these cognitive deficits. There is growing evidence that patients taking second-generation antipsychotic medications perform better on tests of cognitive function than those taking conventional neuroleptics. In addition, there have been a number of medications from other classes being investigated as cognitive enhancers for schizophrenia. Cognitive rehabilitation approaches focus on bypassing, compensating for, or remediating observed impairments in cognitive function. Outcomes for patients have been improved by cognitive remediation, errorless learning, and the use of supportive environments. Combining the newest pharmacologic interventions for cognitive dysfunction with state of the art psychosocial treatments aimed at ameliorating or bypassing deficits is likely to produce the most favorable outcomes for individuals with schizophrenia.     

Synopses of Posters Presented at the International Workshop on Brain Uptake and Utilization of Fatty Acids,Lipids, and Lipoproteins: Application to Neurological Disorders

Thirty-five posters were presented at the Workshop on Brain Uptake And Utilization Of Fatty Acids, Lipids, and Lipoproteins. They were grouped into four categories: (1) mechanisms of lipid uptake and transport to the brain, (2) lipoproteins and polyunsaturated fatty acids, (3) eicosanoids in brain function, and (4) fatty acids and lipids in brain disorders. This article summarizes the highlights of the research presented in these posters. The individual abstracts follow these synopses.     

通脉养心口服液与通脉养心丸药理作用比较

对通脉养心口服液及丸剂进行了药理作用的比较，结果表明，２种剂型基本具有相同的心血管药理作用，但在作用强度上不完全相同，在抑制心肌缺血猎ＳＴ段抬高及提高减压缺氧耐力上，口服液较丸剂作用稍强，在抑制大鼠实验性血栓形成上，丸剂比口服液作用稍强。     

Chronic hepatitis B virus infection in patients with “Normal” ALT levels

Not many data exist to guide us in the management of patients with chronic hepatitis B virus infection and “normal” alanine aminotransferase levels. Many of these patients may not have normal levels on long-term follow-up or when the upper limit of normal is determined from a truly healthy reference population. These patients may have significant histologic disease and benefit from further investigation or treatment. This article focuses on the disease course of such patients.